“In the third quarter, we delivered total revenue and non-GAAP EPS above the high end of our guidance ranges, while continuing to advance our position in the rapidly evolving CX AI market.” ...

“Uniqueness, innovation and focus: three key factors to keep the promises of our last Capital Markets Day. Deliveries of our F80 supercar and personalizations, led by the Ferrari 296 Speciale family, ...

“We are pleased with our third quarter results, which featured meaningful net sales and EPS growth, along with healthy free cash flow. Our refreshment beverages portfolio maintained its double-digit ...

“Ashland closed fiscal 2026 with strong commercial performance across our higher-growth Life Sciences and Personal Care businesses, as well as coatings and performance specialties within Specialty ...

GAAP net income includes $57 million of unrealized gains on commodity derivatives, $19 million of favorable inventory valuation adjustments, $10 million loss on disposal of assets and impairment ...

Non-GAAP figure excludes share-based compensation of $288.2 million, restructuring charges of $4.1 million, payroll tax on share-based compensation of $5.6 million and amortization of acquired ...

“We delivered another record quarter underpinned by strong execution and broad-based demand trends with Elo Touch contributing to our double-digit growth as customers prioritize automating their ...

Adjusted EPS excludes discontinued Global Print operations ($50 million net earnings; $0.12 per share). GAAP diluted EPS was $0.78 versus $0.94; the prior-year GAAP figure included a $160 million ...

“The third quarter marked meaningful progress for CRISPR Therapeutics. CASGEVY is reaching more patients, including younger children following new approvals in the U.K. and the Middle East, and the ...

Looking ahead to 2030, our model projects PSNY could trade at an average price of $14.89, with a potential range between $11.17 and $18.62. This represents a potential 237.7% return from today’s price ...

Adjusted diluted EPS reported as nil (—). GAAP diluted EPS of $0.02 includes a $101 million pre-tax ($62 million after-tax) benefit plan termination settlement cost, $10 million of acquisition and ...